Why MetLife, Inc. (MET) stock moved
No significant move on Nov 20, 2026 (−2.0%, close-to-close). Latest notable session: Nov 5, 2026.
Why MetLife, Inc. (MET) fell 3.1% on November 5, 2026
MetLife, Inc. (MET) fell 3.1% on November 5, 2026, closing at $99.75 versus $102.89 the prior session (close-to-close, from daily closes). After reporting Q3 2026 earnings on 2026-11-04. The company beat EPS consensus by 0.36%, reporting $2.78 vs. estimate $2.77, driven by higher investment income; however, revenue missed expectations. Source: FMP price data; BestStocks detection.
MetLife, Inc. (MET) moved -4.55% from $104.50 to $99.75 on 2026-11-05, the day after reporting Q3 2026 earnings on 2026-11-04. The company beat EPS consensus by 0.36%, reporting $2.78 vs. estimate $2.77, driven by higher investment income; however, revenue missed expectations.
What to watch next: MetLife's next earnings are scheduled for 2027-02-03 with a consensus EPS estimate of $2.62.
Earlier sessions that moved MET
- −4.6%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
- +2.8%No breaking news catalyst was identified; the advance may reflect positioning ahead of the company's Q3 2026 earnings announcement scheduled for November 4, 2026 after market close (Business Wire, October 7).
MetLife, Inc. (MET) shares fell 2.0% to $95.67 as of November 21, 2026, a modest decline from the prior close of $97.60. BestStocks flagged the session as a major change for MET. The move is tied to company news. Below, we break down what changed for MET, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
Company News
MetLife Investment Management closed a $370 million opportunistic real estate debt fund, expanding its institutional asset management capabilities. Fund closure demonstrates MIM's growth in alternative assets, potentially diversifying MET's revenue streams beyond traditional insurance operations.
What it means for MetLife, Inc. investors
For MetLife, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 2.0%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $108.78, implying +13.7% upside from $95.67. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality low (46/100). With earnings roughly 74 days out, the next report is the most likely near-term test of the move.
MET price reaction
MET last traded at $95.67, down $1.93 (-1.98%) from the previous close of $97.60. The session traded on 1.3× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $95.67 and $103.57, and it currently sits about 0% of the way up that band.
Bullish and bearish analyst opinions on MetLife, Inc. (MET)
The consensus analyst price target on MetLife, Inc. (MET) is $108.78, 13.7% above the recent $95.67. Over the past 90 days analysts logged 1 upgrade, 11 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MET line up.
The bullish case
- Wall Street's consensus price target of $108.78 implies +13.7% upside from $95.67.
- The Street's most bullish target is $112.00 (+17.1%).
- 1 analyst upgrade in the past 90 days, most recently Piper Sandler to Overweight (2026-09-22).
- Positive price momentum.
The bearish case
- Negative session, down 2.0%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Nov 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for MET
Frequently asked questions about MET
Why did MetLife, Inc. (MET) stock move?
MetLife, Inc. (MET) fell 3.1% on November 5, 2026, closing at $99.75 versus $102.89 the prior session (close-to-close, from daily closes). After reporting Q3 2026 earnings on 2026-11-04. The company beat EPS consensus by 0.36%, reporting $2.78 vs. estimate $2.77, driven by higher investment income; however, revenue missed expectations. Source: FMP price data; BestStocks detection.
How much did MET stock fall?
MET lost 1.98% ($1.93) versus the prior close of $97.60, last trading at $95.67 on 1.3× average volume.
When is MetLife, Inc.'s next earnings date?
MET's next earnings report is estimated for 2027-02-03 — about 74 days away.
What is the analyst price target for MET?
The consensus analyst price target for MET is $108.78, about 13.7% above the current $95.67. Over the past 90 days, analysts recorded 1 upgrade, 11 maintains, and 0 downgrades.
How BestStocks tracks MET
This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for MET, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
